封面
市场调查报告书
商品编码
1535092

心跳手术系统的全球市场 - 市场规模(依细分市场)、占有率、监管、偿付、治疗、预测(~2033年)

Beating Heart Surgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

心臟供血不足的冠心病(CHD)患者可以透过冠状动脉绕道手术(CABG)进行手术治疗。CHD并不都是透过冠状动脉绕道术治疗,还有其他选择,例如改变生活方式、药物和血管成形术。特别是,经皮冠状动脉成形术(PCI)是 CABG 的替代治疗方法,由于其微创性质,已经并将继续流行。 CABG 仍然比任何其他治疗方法更有效。 CABG 手术有两种基本方法。体外循环CABG 和非体外循环CABG。非体外循环CABG,也称为心跳绕道手术,不需要心肺机。 On-pump 被认为是传统方法。目前,缺乏证据显示两种方法的临床结果有显着差异。

本报告研究和分析了全球心跳手术系统市场,提供了有关主要参与者、市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要内容如下。

商用心跳手术系统与不断变化的竞争格局

  • 对主要产业趋势的考察
  • 按心跳手术系统市场细分的年收入和市场前景(2015-2033年)
  • 依细分市场划分的手术总数、单位数量、平均售价和市场价值的详细资料

全球、区域和国家层面的特定市场考量

  • 依地区细分全球趋势的特定市场定性资讯和国家考察
  • 心跳手术系统市场SWOT分析
  • 心跳手术系统市场竞争动态的思考与趋势

透过对医疗保健系统的真实、全面的了解来促进市场理解。市场进入部分还提供有关偿付政策和监管环境的讯息,能够更深入地研究市场动态。

  • 各国医疗保健系统概览
  • 依国家/地区划分的偿付政策
  • 各国医疗科技监理状况

目标公司

  • Medtronic Plc
  • Getinge AB
  • Terumo Corp
  • Beijing Hangtian Kadi Technology R&D Institute
  • Jinhwa Medical Co Ltd
  • Sumitomo Bakelite Co Ltd
  • Vitalcor, Inc.
  • 其他
简介目录
Product Code: GDME650MM

Beating Heart Surgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Beating heart surgery systems are utilized while performing an off-pump Coronary Artery Bypass Grafting (CABG) procedure. Surgeons use special positioners and stabilizers to position and stabilize the part of the heart on which they are operating on. The heart continues to beat during the operation. Surgery on a beating heart helps reduce the risk for complications associated with temporarily stopping the heart during surgery.

Patients suffering form Coronary Heart Disease (CHD) resulting in insufficient blood supply to the heart can be treated surgically through a CABG procedure. CHD isn't always treated with CABG as other options are also available such as lifestyle changes, medicine, angioplasty and etc. Particularly, percutaneous coronary intervention (PCI) is an alternative to CABG that has been growing and continues to grow in popularity due to its minimally invasive nature. Currently, CABG is still more effective than any other treatment. There are two basic ways of performing a CABG procedure: On-pump and Off-pump CABG. Off-pump CABG, also called beating heart bypass grafting, does not require a heart-lung bypass machine. On-pump is considered to be the traditional method. There is currently a lack of evidence demonstrating significant difference in clinical outcomes between the two approaches.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Beating Heart Surgery Systems and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Beating Heart Surgery Systems market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Beating Heart Surgery Systems market.
  • Competitive dynamics insights and trends provided for Beating Heart Surgery Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Getinge AB, Terumo Corp, Beijing Hangtian Kadi Technology R&D Institute, Jinhwa Medical Co Ltd, Sumitomo Bakelite Co Ltd, Vitalcor, Inc., and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Beating Heart Surgery Systems marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Beating Heart Surgery Systems market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Beating Heart Surgery Systems market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Beating Heart Surgery Systems market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.